news
Federal Court Blocks Colorado's Amgen Drug Price Cap
A federal judge paused Colorado's first-ever state-imposed price cap on Amgen's blockbuster arthritis drug, Enbrel. This ruling follows a lawsuit filed by Amgen, arguing the state panel lacked the authority to set prices. It means consumers in Colorado will continue to pay the current market price for Enbrel, rather than the state-mandated lower price.
A federal judge paused Colorado's first-ever state-imposed price cap on Amgen's blockbuster arthritis drug, Enbrel. This ruling follows a lawsuit filed by Amgen, arguing the state panel lacked the authority to set prices. It means consumers in Colorado will continue to pay the current market price for Enbrel, rather than the state-mandated lower price.
The architecture take
States trying to put a lid on drug prices just hit a big legal wall. The pharmaceutical industry is coming out swinging, making it clear they won't let states dictate their pricing strategy without a fight. This sets a precedent for any future state-level attempts to lower drug costs.